维普期刊资源整合服务平台（V6.5）

137篇 您的检索式：作者名="Waters SM"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Intensive lipid lowering with atorvastatin in patients with stable coronary disease 显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，：	1
2	Intensive lipid lowering with atorvastatin in patients with stable coronary disease 显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，14：	1
3	Treating to New Targets(TNT) intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，36，：	1
4	Intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，：	1
5	Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes显示文摘	Waters DD Ho JE Boekholdt SM etal	2013	J Am Coll Cardiol2013，61，2：	1
6	For the Treating to New Targets (TNT) investigators ,intensive lipid lowering wit h atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，：	1
7	Intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	Grundy SM Waters DD	2005	N Engl J Med2005，352，：	1
8	C5a, but not C3a, increas- es VEGF secretion in ARPE-19 human retinal pigment epithelialcells 显示文摘	Cortright DN Meade R Waters SM	2009	Curr Eye Res2009，34，1：	1
9	Three second chromosome-linked clustered Cyp6genes show differential constitutive and barbital-in-duced expression in DDT-resistant and susceptiblestrains of Drosophila melanogaster显示文摘	Sushmita M Dombrowski SM Waters LC	1996	Gene1996，180，12：	1
10	Intensive lipid lowering with tervastatinln patients with stable eononary disease显示文摘	Larose JC Grundy SM Waters DD	2005	N Eng J Med2005，352，：	1
11	Intensive lipid lower- ing with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，14：	1
12	Intensive lipid lowering with atorvastatin in patients with stable coro-nary disease显示文摘	LAROSA JC GRUNTY SM WATERS DD	2005	N Engl J Med2005，352，：	1
13	Intensive Lipid Lowering with Atorvastatin in Patients with stable coronary disease显示文摘	Grundy SM waters DD	2005	N Eng J Med2005，352，14：	1
14	Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica 显示文摘	Kim SM Waters P Vincent A	2009	Muir Scler2009，15，9：	1
15	Intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，14：	1
16	Intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD		0，，14：	1
17	Intensive lipid lowering with atorvastatin in patients with stable coronary disease 显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，14：	1
18	Intensive lipid lowering with atorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DD	2005	N Engl J Med2005，352，：	1
19	Three second chromosome- linked clustered Cyp6 genes show differential constitutive and barbital - in - duced expression in DDT - resistant and susceptible strains of Drosophila melanogaster 显示文摘	Sushmita M Dombrowski SM Waters LC	1996	Gene1996，180，12：	1
20	Intensive lipid lowering withatorvastatin in patients with stable coronary disease显示文摘	LaRosa JC Grundy SM Waters DDE	2005	N Engl J Med2005，352，14：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示